Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways
about
A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.Genome-scale modeling of NADPH-driven β-lapachone sensitization in head and neck squamous cell carcinoma.Using DNA devices to track anticancer drug activity.Mutant KRAS associated malic enzyme 1 expression is a predictive marker for radiation therapy response in non-small cell lung cancer.The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy.
P2860
Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@ast
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@en
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@nl
type
label
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@ast
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@en
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@nl
prefLabel
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@ast
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@en
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@nl
P2093
P2860
P356
P1476
Expanding antitumor therapeuti ...... phosphate-biogenesis pathways
@en
P2093
David Boothman
David Gerber
Gaurab Chakrabarti
P2860
P356
10.2147/CPAA.S79760
P407
P577
2015-01-01T00:00:00Z